Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guishen Huoxue Decoction is a Traditional Chinese Medicine (TCM) herbal formula primarily investigated for the treatment of intrauterine adhesions (IUA), also known as Asherman's syndrome. The decoction is formulated based on the TCM principles of tonifying the kidney (Guishen) and activating blood circulation to resolve stasis (Huoxue). It is typically used as an adjuvant therapy following hysteroscopic transcervical resection of adhesions (TCRA) to promote the regeneration of the endometrium, improve uterine hemodynamics, and reduce the risk of adhesion recurrence. The formula generally consists of a combination of herbs such as *Rehmannia glutinosa*, *Angelica sinensis*, *Salvia miltiorrhiza*, and *Cuscuta chinensis*, which are thought to synergistically modulate inflammatory responses and fibrotic pathways.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guishen Huoxue Decoction.